Lu-177 PSMA
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Evaluation of Targeted Radionuclide Therapy of Lu-177 PSMA in Patients With Compromised Renal and/or Bone Marrow Function (NCT07169825) | M.D. Anderson Cancer Center | 2026-03-30 |
Track Lu-177 PSMA automatically
Every clearance here is in the API, with alerts when new ones post.